USA, May 2024 - Plan for Regulatory Reform under the Coordinated Framework for the Regulation of Biotechnology. 

This plan contributes to the implementation of the Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure Bioeconomy, which among other objectives, "aims to support the safe use of biotechnology products by clarifying and streamlining regulations in service of a science- and risk-based, predictable, efficient, and transparent regulatory system". The regulatory plan covers A. Modified plants, B. Modified animals, C. Modified microorganisms, D. Human drugs, biologics, and medical devices, E. Cross-cutting issues.

Source: US Department of Agriculture, US Environmental Protection Agency, US Food and Drug Administration.